| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |